LifeStance Health Group, Inc. (LFST) vs Oruka Therapeutics, Inc. (ORKA)

A side-by-side comparison of LifeStance Health Group, Inc. and Oruka Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LFST vs ORKA

growth of $100 · dividends reinvested · last 5y
LFST -44.2% (-11.0%/yr)ORKA +224.8% (+26.6%/yr)ORKA compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020222023202420252026$56$325
LFST ORKA

LFST vs ORKA: by the numbers

  • •ORKA is the larger company ($4.81B vs $4.68B market cap).
  • •LFST is profitable (3.19% net margin) while ORKA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricLFSTORKA
P/E ratio92.98N/A
Forward P/E75.13N/A
P/S ratio2.95N/A
P/B ratio3.174.33
EV / EBITDA34.98N/A
FCF yield3.72%N/A

Profitability

MetricLFSTORKA
Gross margin33.56%0.00%
Operating margin4.95%0.00%
Net margin3.19%0.00%
ROE3.43%-11.92%
ROIC3.03%-13.88%

Growth (annualized)

MetricLFSTORKA
Revenue CAGR (5Y)24.79%N/A
Total return CAGR (5Y)-1.46%32.76%

Frequently asked

Is LFST or ORKA more profitable?
LFST runs the higher net margin — LFST at 3.19% versus ORKA at 0.00%.
How have LFST and ORKA total returns compared?
Over the past 5 years, LFST delivered -1.46% and ORKA delivered 32.76% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.